Radnor, Pa. — January 29th, 2025 — Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full year of 2024 after the market close on Wednesday, February 26th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET.
Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.
Certara also announced that company management will participate in the following investor conferences:
- Leerink Partners Global Healthcare Conference
Date and Time: Tuesday, March 11th at 1:00PM ET - Barclays 27th Annual Global Healthcare Conference
Date and Time: Wednesday, March 12th at 11:30AM ET
Live and archived webcasts of these events will be available on the “Investors” section of the Certara website at https://ir.certara.com/.
Certara（サターラ）について
サターラは、モデリング＆シミュレーション・ソフトウェアと技術を用いて、従来の創薬・開発を変革し、医薬品をよりスピーディーに患者さんに届けることをミッションとしています。製薬、教育機関、規制当局のお客様 2,400人以上、66ヵ国にてサターラの技術やサービスが活用されています。詳細は弊社ホームページをご覧ください。
投資家の皆様：
David Deuchler
Gilmartin Group
ir@certara.com
報道機関の皆様：
赤津笑美 (emi.akatsu@certara.com)
certara@pancomm.com
